CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 31 - 40 of 886
Study Number Lead Group Study Title CIRB Study Status
A211601 Alliance Evaluation of Mammographic Breast Density Effect of Aspirin: A companion study to Alliance Study A011502 Cancer Prevention and Control CIRB Available to Open
A221805 Alliance Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study Cancer Prevention and Control CIRB Available to Open
A031102 Alliance A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel; Ifosfamide; and Cisplatin (TIP) with High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors Adult CIRB - Late Phase Emphasis Available to Open
A011801 Alliance The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinb Adult CIRB - Late Phase Emphasis Available to Open
A071801 Alliance Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS (FSRS) for Resected Metastatic Brain Disease Adult CIRB - Late Phase Emphasis Available to Open
A151804 Alliance Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events Adult CIRB - Late Phase Emphasis Available to Open
A011202 Alliance A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy Adult CIRB - Late Phase Emphasis Available to Open
A021804 Alliance A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma Adult CIRB - Late Phase Emphasis Available to Open
A071401 Alliance Phase II Trial of SMO/AKT/NF2/CDK Inhibitors in Progressive Meningiomas with SMO/AKT/NF2/CDK Pathway Mutations Adult CIRB - Early Phase Emphasis Available to Open
A191402CD Alliance Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men Cancer Prevention and Control CIRB Available to Open
Displaying 31 - 40 of 886